期刊文献+

制药企业对我国药品可及性工作作用研究 被引量:1

The Research on the Function of Pharmaceutical Corporation in the Drug Access Programme in China
下载PDF
导出
摘要 目的:论证制药企业这一特殊市场主体在保障药品可及性工作中的重要作用。方法:通过规制经济学外部性与外部性分析探讨了制药企业在提高药品可及性工作中的影响,并对制药企业在我国药品可及性工作中的六方面工作重点进行了分析。结果与结论:制药企业对于我国药品可及性工作具有重要作用,并且开展这项工作也会对企业带来利益。 Objective: To discuss the important role that the pharmaceutical corporations play in the drug access programme. Methods: Using the regulation economic methods and the external analysis, discussion was made on the influence of pharmaceutical corporations' increasing the drug access programme, and analysis was made on six aspects. Results and Conclusion: The pharmaceutical corporations can play an important role in the drug access programme in China, and this work will bring benefits to the enterprises, too.
出处 《药品评价》 CAS 2010年第22期9-13,共5页 Drug Evaluation
关键词 制药企业 药品可及性 Pharmaceutical Corporation Drug Access Programme
  • 相关文献

参考文献11

  • 1United Nations.International Human Rights Instruments:Compilation of general Comments and General Recommendations Adopted by Human Rights Treaty Bedies.HRI/GEN/1/Rev.7,12May 2003,par.1,p.86.
  • 2Evans T..A Human Right to Health.Third World Quarterly.2002,23(2):197-215.
  • 3卫生部公布第四次国家卫生服务调查主要结果[EB/OL].http://news.ifeng.com/mainland/200902/0227-17.1036608-2.shtml,2009-02-27.
  • 4WHO Medicines Strategy.Framework for Action in Essential Drugs and Medicine Policy 2000-2003[M].Geneva.Switzerland,2001:315-317.
  • 5Paul Hunt.Report of the special Rapporteur on the fight of everyone to the enjoyment of the highest attainable standard of physical and mental health.[RE]United Nations,September 2006.
  • 6W.吉帕.维斯库斯.约翰.M.弗农,小约瑟夫.E.哈林顿.反垄断与管制经济学(第三版)[M].陈雨军等译.北京机械工业出版社,2004.
  • 7Edward M.Epstein.The Corporate Social Policy Process:Beyond Business Ethics.Corporate Social Responsibility and Corporate Social Responsiveness[J].California Management Review.1987,3.
  • 8Freeman,R.Edward and Gilbert,Daniel R.Jr.Corporate Strategyand the Search for Ethics.[M].Prentiee Hall Trade.1988:69.
  • 9郑亮.浅议药品专利保护与公共健康危机的平衡——以TRIPS协议下发展中国家药品的可及性为视角[J].法制与社会,2008(21). 被引量:2
  • 10胡善联,张崖冰,叶露.国家基本药物制度研究[J].卫生经济研究,2007,24(10):3-5. 被引量:75

二级参考文献2

共引文献86

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部